Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
PHIOW was delisted on the 21st of December, 2021.
1 hedge funds and large institutions have $1K invested in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in 2021 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
83% less capital invested
Capital invested by funds: $6K → $1K (-$5K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$5K | -17,722 | Closed |
|
PHIOW Hedge Fund Activity: Q2 2021 in Review
1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) for Q2 2021, worth a combined $1K — down 83% from $6K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of PHIOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $5K sold.
- 1 institutional investor held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) as of Q2 2021, down from 2 in Q1 2021.
- Funds reported $1K of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 stock for Q2 2021, down 83% quarter-over-quarter.
- 0 funds opened new Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 positions in Q2 2021 and 1 closed out, a net change of -1 holder.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 seller in Q2 2021 was UBS Group, an estimated $5K sold.
Based on aggregated 13F filings for Q2 2021.